+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Coronavirus Test Kits Market by Product Type, Specimen Type, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674762
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Coronavirus Test Kits Market grew from USD 19.14 billion in 2023 to USD 22.24 billion in 2024. It is expected to continue growing at a CAGR of 14.68%, reaching USD 49.97 billion by 2030.

The coronavirus test kits market encompasses a variety of diagnostic tools designed to detect the presence of the SARS-CoV-2 virus, which causes COVID-19. This includes RT-PCR kits, rapid antigen tests, and antibody testing kits. The necessity of these kits became evident during the COVID-19 pandemic, emphasizing their critical application in identifying infected individuals to prevent disease spread. Key end-users include hospitals, clinics, diagnostic laboratories, and home-care settings. The market's growth is influenced by several factors, such as increased testing demand due to new variants, government funding, and advancements in testing technologies, like faster and more accurate diagnostics. Additionally, heightened awareness regarding early detection and the need for extensive testing drive the market. However, challenges like supply chain disruptions, regulatory hurdles, and fluctuating demand due to varying pandemic phases hinder consistent growth. Moreover, the high cost of certain test kits and concerns over the accuracy of rapid tests can limit adoption.

To capitalize on market opportunities, companies should focus on developing cost-effective, accurate, and easy-to-use test kits to appeal to a wider audience. There is potential for innovation in multiplex testing kits that can simultaneously detect COVID-19 along with other respiratory infections such as influenza. This would cater to ongoing public health needs beyond the immediate pandemic context. Strengthening distribution and supply chain mechanisms, particularly in emerging markets, can also provide strategic advantages. Companies should consider collaborating with tech firms to integrate AI for better data analysis and forecasting in testing. The market is dynamic and competitive, with a need for adaptability to regulations and patient needs. For business growth, investment in R&D for next-generation testing methods, such as at-home molecular diagnostics, and strategic partnerships for distribution are recommended. Overall, while the market promises potential, navigating the challenges requires innovation and strategic foresight.

Understanding Market Dynamics in the Coronavirus Test Kits Market

The Coronavirus Test Kits Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of COVID-19 pandemic all over the world
    • Significant adoption of NAAT and RT-PCR tests
    • Rising government initiatives and awareness campaigns for detection of COVID-19 syndrome
  • Market Restraints
    • Limited awareness and resistance in utilizing test kits
  • Market Opportunities
    • Surge in approvals and developments of new coronavirus test kits
    • Proliferation of rapid antigen detection tests (RADTs) and point-of-care (POC) testing
  • Market Challenges
    • Concerns regarding technical limitations of test kits

Exploring Porter’s Five Forces for the Coronavirus Test Kits Market

Porter’s Five Forces framework further strengthens the insights of the Coronavirus Test Kits Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Coronavirus Test Kits Market

External macro-environmental factors deeply influence the performance of the Coronavirus Test Kits Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Coronavirus Test Kits Market

The Coronavirus Test Kits Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Coronavirus Test Kits Market

The Coronavirus Test Kits Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Coronavirus Test Kits Market

The Coronavirus Test Kits Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Coronavirus Test Kits Market, highlighting leading vendors and their innovative profiles. These include 1DROP Diagnostics, Abbott Laboratories, ADT Biotech Sdn Bhd, Aldatu Biosciences, altona Diagnostics GmbH, Avellino Lab USA, Inc., bioMérieux SA, Co-Diagnostics, Inc., Curetis GmbH, Danaher Corporations, F. Hoffmann-La Roche AG, GenMark Diagnostics, Inc., Hologic, Inc., Laboratory Corporation of America Holdings, Luminex Corporation, Mylab Discovery Solutions Pvt. Ltd., Perkin Elmer, Inc., Quidel Corporation, Randox Laboratories Ltd., SD Biosensor, Inc., Seegene, Inc., Shenzhen Bioeasy Biotechnology Co., Ltd., Siemens Healthineers AG, SolGent Co.,Ltd., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Coronavirus Test Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Immunoassay Test Strips or Cassettes
      • Antibody
      • Antigen
    • RT-PCR Assay Kits
    • Self-testing Kits
  • Specimen Type
    • Nasal Swab
    • Nasopharyngeal Swab
    • Oropharyngeal Swab
    • Sputum
  • End-User
    • Clinics
    • Diagnostic Centers
    • Homecare
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of COVID-19 pandemic all over the world
5.1.1.2. Significant adoption of NAAT and RT-PCR tests
5.1.1.3. Rising government initiatives and awareness campaigns for detection of COVID-19 syndrome
5.1.2. Restraints
5.1.2.1. Limited awareness and resistance in utilizing test kits
5.1.3. Opportunities
5.1.3.1. Surge in approvals and developments of new coronavirus test kits
5.1.3.2. Proliferation of rapid antigen detection tests (RADTs) and point-of-care (POC) testing
5.1.4. Challenges
5.1.4.1. Concerns regarding technical limitations of test kits
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Coronavirus Test Kits Market, by Product Type
6.1. Introduction
6.2. Immunoassay Test Strips or Cassettes
6.2.1. Antibody
6.2.2. Antigen
6.3. RT-PCR Assay Kits
6.4. Self-testing Kits
7. Coronavirus Test Kits Market, by Specimen Type
7.1. Introduction
7.2. Nasal Swab
7.3. Nasopharyngeal Swab
7.4. Oropharyngeal Swab
7.5. Sputum
8. Coronavirus Test Kits Market, by End-User
8.1. Introduction
8.2. Clinics
8.3. Diagnostic Centers
8.4. Homecare
8.5. Hospitals
9. Americas Coronavirus Test Kits Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Coronavirus Test Kits Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Coronavirus Test Kits Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CORONAVIRUS TEST KITS MARKET RESEARCH PROCESS
FIGURE 2. CORONAVIRUS TEST KITS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. CORONAVIRUS TEST KITS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. CORONAVIRUS TEST KITS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CORONAVIRUS TEST KITS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CORONAVIRUS TEST KITS MARKET DYNAMICS
TABLE 7. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY ANTIGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY RT-PCR ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY SELF-TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY NASAL SWAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY OROPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY SPUTUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CORONAVIRUS TEST KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. CANADA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. CANADA CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 39. CANADA CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. MEXICO CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 43. MEXICO CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CORONAVIRUS TEST KITS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. CHINA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. CHINA CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 61. CHINA CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 62. CHINA CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. INDIA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDIA CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 65. INDIA CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDIA CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. JAPAN CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. JAPAN CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 73. JAPAN CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 74. JAPAN CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. THAILAND CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. THAILAND CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 97. THAILAND CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 98. THAILAND CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. DENMARK CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. DENMARK CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 110. DENMARK CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. EGYPT CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. EGYPT CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 114. EGYPT CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 115. EGYPT CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. FINLAND CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. FINLAND CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 118. FINLAND CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 119. FINLAND CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. FRANCE CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. FRANCE CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 122. FRANCE CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. GERMANY CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 126. GERMANY CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. ITALY CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. ITALY CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 134. ITALY CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. NORWAY CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. NORWAY CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 146. NORWAY CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 147. NORWAY CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. POLAND CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. POLAND CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 150. POLAND CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 151. POLAND CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. QATAR CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. QATAR CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 154. QATAR CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 155. QATAR CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SPAIN CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 170. SPAIN CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. TURKEY CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. TURKEY CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 182. TURKEY CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 183. TURKEY CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM CORONAVIRUS TEST KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM CORONAVIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY TEST STRIPS OR CASSETTES, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM CORONAVIRUS TEST KITS MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM CORONAVIRUS TEST KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. CORONAVIRUS TEST KITS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 193. CORONAVIRUS TEST KITS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Coronavirus Test Kits Market, which are profiled in this report, include:
  • 1DROP Diagnostics
  • Abbott Laboratories
  • ADT Biotech Sdn Bhd
  • Aldatu Biosciences
  • altona Diagnostics GmbH
  • Avellino Lab USA, Inc.
  • bioMérieux SA
  • Co-Diagnostics, Inc.
  • Curetis GmbH
  • Danaher Corporations
  • F. Hoffmann-La Roche AG
  • GenMark Diagnostics, Inc.
  • Hologic, Inc.
  • Laboratory Corporation of America Holdings
  • Luminex Corporation
  • Mylab Discovery Solutions Pvt. Ltd.
  • Perkin Elmer, Inc.
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • SD Biosensor, Inc.
  • Seegene, Inc.
  • Shenzhen Bioeasy Biotechnology Co., Ltd.
  • Siemens Healthineers AG
  • SolGent Co.,Ltd.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information